MuSK MG disease severity correlates with anti-MuSK antibody titers7, particularly IgG4 autoantibodies targeting the MuSK Ig1 domain, which disrupt MuSK-LRP4 interactions8–10. This evidence concerns the gene MUSK and myasthenia gravis.